UniQure files Form 144 to sell 5,295 shares

UniQure N.V. submitted a Form 144 notice to sell 5,295 Ordinary Shares on 06/17/2026 pursuant to a stock option exercise under a 10b5-1 plan.

Rhea-AI Filing Summary

UniQure N.V. submitted a Form 144 notice to sell 5,295 Ordinary Shares on 06/17/2026 pursuant to a stock option exercise under a 10b5-1 plan. The proposed sale lists Citigroup Global Markets, Inc. as the broker and indicates cash proceeds.

The filing also reports two recent dispositions by Jack Kaye: 2,645 shares sold on 06/03/2026 for $79,384.35 and 1,993 shares sold on 06/11/2026 for $53,938.39.

Insights

Securities Compliance Counsel

Form 144 notifies the market of an upcoming sale under a 10b5-1 plan.

The filing lists a proposed sale of 5,295 Ordinary Shares on 06/17/2026, executed via stock option exercise and routed through Citigroup Global Markets, Inc.. The document identifies the transaction type as a 10b5-1 plan, which typically denotes a pre-arranged trading instruction.

Cash treatment is stated as cash and recent sales by Jack Kaye are disclosed (2,645 and 1,993 shares on 06/03/2026 and 06/11/2026, respectively). Further public filings would show consummation details.

Key Figures

Proposed sale: 5,295 shares Prior disposition: 2,645 shares Prior disposition: 1,993 shares +1 more

4 metrics

Proposed sale 5,295 shares sale date <date>06/17/2026</date> via stock option exercise

Prior disposition 2,645 shares sold on <date>06/03/2026</date> for <money>$79,384.35</money>

Prior disposition 1,993 shares sold on <date>06/11/2026</date> for <money>$53,938.39</money>

Broker Citigroup Global Markets, Inc. listed as broker for the proposed sale

Key Terms

10b5-1 plan, Form 144, Ordinary Shares

3 terms

10b5-1 plan regulatory

"Stock option exercise pursuant to 10b51 plan"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Ordinary Shares market

"Ordinary Shares | Citigroup Global Markets, Inc"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UniQure's Form 144 (QURE) report?

The filing reports a proposed sale of 5,295 Ordinary Shares on 06/17/2026 via stock option exercise under a 10b5-1 plan, with Citigroup Global Markets, Inc. named as broker.

Who is authorized to handle the sale listed in the QURE Form 144?

Citigroup Global Markets, Inc. is identified as the broker for the proposed transaction on 06/17/2026. The filing specifies the sale method as a stock option exercise under a 10b5-1 plan and cash proceeds.

What recent share dispositions by insiders does the Form 144 show for QURE?

The filing discloses two recent sales by Jack Kaye: 2,645 shares on 06/03/2026 for $79,384.35 and 1,993 shares on 06/11/2026 for $53,938.39. These are reported as past three months sales.

Does the Form 144 state how proceeds will be used for the QURE sale?

The filing indicates the transaction is an option exercise and lists cash as the treatment for the current proposed sale. The document does not specify any further allocation or use of proceeds.

Is the QURE sale part of a pre-arranged trading plan?

Yes. The proposed sale of 5,295 shares on 06/17/2026 is described as a stock option exercise pursuant to a 10b5-1 plan, indicating a pre-arranged trading instruction was used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001376099
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Kaye Jack
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	5295	225393.40	63067485	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/17/2026	Stock option exercise pursuant to 10b51 plan	UniQure N.A.			5295	06/17/2026	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Kaye paasheuvelweg 25 a Amsterdam P7 1105BP	Ordinary Shares	06/03/2026	2645	79384.35
Jack Kaye paasheuvelweg 25 a, AMSTERDAM P7 1105BP	Ordinary shares	06/11/2026	1993	53938.39

144: Remarks and Signature

Remarks	Shares being sold are pursuant to the 10b51 plan adopted June 2025
Date of Notice	06/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature on File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)